Zonisamide - 98%, high purity , Sodium channel alpha subunit blocker, CAS No.68291-97-4, Sodium channel alpha subunit blocker

Item Number

Z163001

• Synonyms: DB00909 | ZONISAMIDE (MART.) | Zonisamide (USAN:USP:INN:BAN:JAN) | ZONISAMIDE [ORANGE BOOK] | Benzo(d)isoxazol-3-yl-methanesulfonamide | FT-0675931 | MLS001306491 | Trerief | 1-(1,2-benzisoxazol-3-yl)methanesulfonamide | BDBM10888 | Excegram | BCP28480 |
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Broad spectrum antiepileptic with multiple mechanisms of action. Blocks voltage-sensitive Na + and T-type Ca 2+ channels and stimulates BKCa channels. Modulates GABA, glutamate, cholinergic and monoamine neurotransmission.
• Shipped In: Normal
• Grade: Moligand™
• Action Type: BLOCKER, INHIBITOR
• Mechanism of action: Sodium channel alpha subunit blocker
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.